FDY-5301
N/A
Report date: 2022/12/17 15:14:18
NME
Base Information
Drug NameFDY-5301
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[5]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[7]
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesFaraday
China Registration ClassN/A
Develop Information
Active CompaniesFaraday Pharmaceuticals IncActimed Therapeutics Ltd
Inactive CompaniesN/A
Active Indications +[4]
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A